Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. In this series of lectures, I present IMPRES and TI

Cancer immunotherapy: predict outcomes better with combination biomarkers

  • Vews: 2,090
42
Shared

Event Cancer immunotherapy: predict outcomes better with combination biomarkers

Science & Technology Cancer immunotherapy: predict outcomes better with combination biomarkers

Cancer immunotherapy: predict outcomes better with combination biomarkers Shanghai

Cancer immunotherapy: predict outcomes better with combination biomarkers Science & Technology Shanghai
Cancer immunotherapy: predict outcomes better with combination biomarkers China
  • Shanghai China
  • Start: Oct 23 2019 19:00
  • Finish: Oct 23 2019 22:00
  • Time zone: Asia/Shanghai
This event is finished
Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. In this series of lectures, I present IMPRES and TIDE, two of the best predictors of cancer immunotherapy outcomes.
I also show an easy way to combine them and improve their predictions, using a combination biomarker. Finally, I make suggestions of practical ways to contribute to research on this topic.
Speaker: Mostapha Benhenda, bioinformatician at Melwy.com
You will receive the link to the lectures by registering to this event.
Contact - Cancer immunotherapy: predict outcomes better with combination biomarkers

Other Events in Shanghai China